Systemically Administered Brain-Targeted Nanoparticles Transport Peptides across the Blood—Brain Barrier and Provide Neuroprotection

Caspases: Enemies Within

Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857 · see citing works

Cellular survival: a play in three Akts

Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · see citing works

Pericytes regulate the blood–brain barrier

Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843 · see citing works

Biodegradation, biodistribution and toxicity of chitosan

Kean, T., & Thanou, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.004 · Cited by 1,837 · see citing works

Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide Synthase

Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman, M. C., & Moskowitz, M. A. (1994) · Science · doi:10.1126/science.7522345 · Cited by 1,562 · see citing works

Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery

Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270 · see citing works

Nanoparticulate systems for brain delivery of drugs.

Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · see citing works

Nanoparticulate systems for brain delivery of drugs

Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958 · see citing works

Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia

Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A. N., Tomaselli, K. J., Yuan, J., & Moskowitz, M. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03659.1998 · Cited by 892 · see citing works

Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage

Hara, H., Friedlander, R. M., Gagliardini, V., Ayata, C., Fink, K., Huang, Z., Shimizu‐Sasamata, M., Yuan, J., & Moskowitz, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2007 · Cited by 835 · see citing works

Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery

Yemişçi, M., Özdemir, Y., Vural, A., Can, A., Topalkara, K., & Dalkara, T. (2009) · Nature Medicine · doi:10.1038/nm.2022 · Cited by 780 · see citing works

Induction of Caspase-3-Like Protease May Mediate Delayed Neuronal Death in the Hippocampus after Transient Cerebral Ischemia

Chen, J., Nagayama, T., Jin, K., Stetler, R. A., Zhu, R. L., Graham, S. H., & Simon, R. P. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04914.1998 · Cited by 704 · see citing works

Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke

Knowland, D., Arac, A., Sekiguchi, K. J., Hsu, M., Lutz, S. E., Perrino, J., Steinberg, G. K., Barres, B. A., Nimmerjahn, A., & Agalliu, D. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.003 · Cited by 703 · see citing works

Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system

Amidi, M., Romeijn, S. G., Borchard, G., Junginger, H. E., Hennink, W. E., & Jiskoot, W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.014 · Cited by 415 · see citing works

Development and Brain Delivery of Chitosan−PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26

Aktaş, Y., Yemişçi, M., Andrieux, K., Gürsoy, R. N., Alonso, M. J., Fernández-Megía, E., Novoa-Carballal, R., Quiñoá, E., Riguera, R., Sargon, M. F., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050217o · Cited by 318 · see citing works

Neurotrophins and neurodegeneration

Dawbarn, D., & Allen, S. J. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00487.x · Cited by 210 · see citing works

Role of Endothelial Nitric Oxide Generation and Peroxynitrite Formation in Reperfusion Injury After Focal Cerebral Ischemia

Özdemir, Y., Bolay, H., Sarıbaş, O., & Dalkara, T. (2000) · Stroke · doi:10.1161/01.str.31.8.1974 · Cited by 197 · see citing works

A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection

Karataş, H., Aktaş, Y., Özdemir, Y., Bodur, E., Yemişçi, M., Caban-Toktas, S., Vural, A., Pınarbaşlı, O., Çapan, Y., Fernández-Megía, E., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4246-09.2009 · Cited by 187 · see citing works

Expression of Interleukin-1β Converting Enzyme Gene Family and bcl-2 Gene Family in the Rat Brain following Permanent Occlusion of the Middle Cerebral Artery

Asahi, M., Hoshimaru, M., Uemura, Y., Tokime, T., Kojima, M., Ohtsuka, T., Matsuura, N., Aoki, T., Shibahara, K., & Kikuchi, H. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199701000-00003 · Cited by 156 · see citing works

Basic Fibroblast Growth Factor Dilates Rat Pial Arterioles

Rosenblatt, S., Irikura, K., Caday, C. G., Finklestein, S. P., & Moskowitz, M. A. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.11 · Cited by 78 · see citing works

Programmed Cell Death Mechanisms in Neurological Disease

Bredesen, D. E. (2008) · Current Molecular Medicine · doi:10.2174/156652408784221315 · Cited by 62 · see citing works

Lysosomal rupture, necroapoptotic interactions and potential crosstalk between cysteine proteases in neurons shortly after focal ischemia

Toprak, M. K., Özdemir, Y., Gürer, G., Erdener, Ş. E., Erdemlı, E., Can, A., & Dalkara, T. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.003 · Cited by 57 · see citing works

Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia

Ma, J., Qiu, J., Hirt, L., Dalkara, T., & Moskowitz, M. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704075 · Cited by 55 · see citing works

Spatiotemporal Correlations between Blood-Brain Barrier Permeability and Apparent Diffusion Coefficient in a Rat Model of Ischemic Stroke

Taheri, S., Candelario‐Jalil, E., Estrada, E. Y., & Rosenberg, G. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006597 · Cited by 39 · see citing works

bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice

Huang, Z., Chen, K., Huang, P. L., Finklestein, S. P., & Moskowitz, M. A. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.3.h1401 · Cited by 36 · see citing works

Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides

Yemişçi, M., Caban-Toktas, S., Fernández-Megía, E., Çapan, Y., Couvreur, P., & Dalkara, T. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7571-6_36 · Cited by 30 · see citing works

Cell death and survival mechanisms are concomitantly active in the hippocampus of patients with mesial temporal sclerosis

Dericioğlu, N., Söylemezoğlu, F., Özdemir, Y., Akalan, N., Saygı, S., & Dalkara, T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.050 · Cited by 19 · see citing works

Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides

Caban-Toktas, S., Çapan, Y., Couvreur, P., & Dalkara, T. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-536-7_27 · Cited by 16 · see citing works

Lack of inhibitory effects of the anti‐fibrotic drug imatinib on endothelial cell functions in vitro and in vivo

Venalis, P., Maurer, B., Akhmetshina, A., Busch, N., Dees, C., Stürzl, M., Zwerina, J., Jüngel, A., Gay, S., Schett, G. A., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00492.x · Cited by 11 · see citing works

Untitled work

(1999) · doi:10.1002/1531-8249(199904)45:4

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works

Blood-brain barrier dysfunction and recovery after ischemic stroke

Jiang, X., Andjelkovic, A. V., Zhu, L., Yang, T., Bennett, M. V. L., Chen, J., Keep, R. F., & Shi, Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.001 · Cited by 946 · see citing works

Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies

Ding, S., Khan, A. I., Cai, X., Song, Y., Lyu, Z., Du, D., Dutta, P., & Lin, Y. (2020) · Materials Today · doi:10.1016/j.mattod.2020.02.001 · Cited by 448 · see citing works

Targeting the transferrin receptor for brain drug delivery

Johnsen, K. B., Burkhart, A., Thomsen, L. B., Andresen, T. L., & Moos, T. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101665 · Cited by 371 · see citing works

Ligand-installed nanocarriers toward precision therapy

Mi, P., Cabral, H., & Kataoka, K. (2020) · Advanced Materials · doi:10.1002/adma.201902604 · Cited by 350 · see citing works

Chitosan and chitosan coating nanoparticles for the treatment of brain disease

Yu, S., Xu, X., Feng, J., Liu, M., & Hu, K. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.012 · Cited by 340 · see citing works

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305 · see citing works

Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier

Sharma, G., Sharma, A. R., Lee, S., Bhattacharya, M., Nam, J., & Chakraborty, C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.056 · Cited by 194 · see citing works

Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors

Zhang, L., Liu, Y., Huang, H., Xie, H., Zhang, B., Xia, W., & Guo, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114536 · Cited by 177 · see citing works

Impact of microRNAs on ischemic stroke: From pre- to post-disease

Li, G., Morris-Blanco, K. C., Lopez, M. S., Yang, T., Zhao, H., Vemuganti, R., & Luo, Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.002 · Cited by 159 · see citing works

Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases

Ballance, W. C., Qin, E. C., Chung, H. J., Gillette, M. U., & Kong, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119292 · Cited by 156 · see citing works

Nanomaterials for Drug Delivery to the Central Nervous System

Teleanu, D. M., Neguț, I., Grumezescu, V., Grumezescu, A. M., & Teleanu, R. I. (2019) · Nanomaterials · doi:10.3390/nano9030371 · Cited by 156 · see citing works

Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood–brain barrier

Azhari, H. N., Strauss, M., Hook, S. M., Boyd, B. J., & Rizwan, S. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.001 · Cited by 118 · see citing works

Thrombin-Responsive, Brain-Targeting Nanoparticles for Improved Stroke Therapy

Guo, X., Deng, G., Liu, J., Zou, P., Du, F., Liu, F., Chen, A. T., Hu, R., Li, M., Zhang, S., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b04787 · Cited by 117 · see citing works

Targeting specific cells in the brain with nanomedicines for CNS therapies

Zhang, F., Lin, Y.-A., Kannan, S., & Kannan, R. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.013 · Cited by 110 · see citing works

Advances in developing therapeutic strategies for Alzheimer's disease

Nguyen, T. T., Nguyen, T. T. D., Nguyen, T. K. O., Vo, T. K., & Giau, V. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111623 · Cited by 107 · see citing works

Nanocomposites as biomolecules delivery agents in nanomedicine

Bamburowicz‐Klimkowska, M., Popławska, M., & Grudziński, I. P. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0479-x · Cited by 106 · see citing works

Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping

Kumar, A., Tan, A., Wong, J. K. L., Spagnoli, J. C., Lam, J. M., Blevins, B., Natasha, G., Thorne, L. W., Ashkan, K., Xie, J., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201700489 · Cited by 97 · see citing works

Phenolic compounds that cross the blood–brain barrier exert positive health effects as central nervous system antioxidants

Velásquez-Jiménez, D., Corella‐Salazar, D. A., Zuñiga-Martínez, B. S., Domínguez-Avila, J. A., Montiel‐Herrera, M., Salazar‐López, N. J., Rodrigo-García, J., Villegas‐Ochoa, M. A., & González-Aguilar, G. A. (2021) · Food & Function · doi:10.1039/d1fo02017j · Cited by 83 · see citing works

Targeting Malignant Brain Tumors with Antibodies

Razpotnik, R., Novak, N., Šerbec, V. Č., & Rajčević, U. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01181 · Cited by 79 · see citing works

BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS

Peluffo, H., Unzueta, U., Negro‐Demontel, M. L., Xu, Z., Váquez, E., Ferrer‐Miralles, N., & Villaverde, A. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.004 · Cited by 76 · see citing works

Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives

La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74 · see citing works

Nano-enabled delivery of diverse payloads across complex biological barriers

Ross, K. A., Brenza, T. M., Binnebose, A. M., Phanse, Y., Kanthasamy, A. G., Gendelman, H. E., Salem, A. K., Bartholomay, L. C., Bellaire, B. H., & Narasimhan, B. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.039 · Cited by 72 · see citing works

Advances of nano drug delivery system for the theranostics of ischemic stroke

Lv, W., Liu, Y., Li, S., Lv, L., Lu, H., & Xin, H. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01450-5 · Cited by 69 · see citing works

Neuro‐Nano Interfaces: Utilizing Nano‐Coatings and Nanoparticles to Enable Next‐Generation Electrophysiological Recording, Neural Stimulation, and Biochemical Modulation

Young, A. T., Cornwell, N., & Daniele, M. A.-A. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201700239 · Cited by 70 · see citing works

Pathophysiology of Long Non-coding RNAs in Ischemic Stroke

Ren, W., & Yang, X. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00096 · Cited by 66 · see citing works

Advancements in the Blood–Brain Barrier Penetrating Nanoplatforms for Brain Related Disease Diagnostics and Therapeutic Applications

Thangudu, S., Cheng, F., & Su, C. (2020) · Polymers · doi:10.3390/polym12123055 · Cited by 65 · see citing works

Therapeutic benefits of nanoparticles in stroke

Panagiotou, S., & Saha, S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00182 · Cited by 63 · see citing works

Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport

Fang, F., Zou, D., Wang, W., Yin, Y., Yin, T., Hao, S., Wang, B., Wang, G., & Wang, Y. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.02.056 · Cited by 63 · see citing works

Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?—Current Status

Bulygin, K. V., Beeraka, N. M., Saitgareeva, A. R., Nikolenko, V. N., Фанилевич, Г. И., Beylerli, O., Ахмадеева, Л. Р., Михалева, Л. М., Solis, L. F. T., Herrera, A. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186728 · Cited by 60 · see citing works

Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives

Ediriweera, G. R., Chen, L., Yerbury, J. J., Thurecht, K. J., & Vine, K. L. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00297 · Cited by 56 · see citing works

Blood–Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke

Nilles, K. L., Williams, E. I., Betterton, R. D., Davis, T. P., & Ronaldson, P. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031898 · Cited by 56 · see citing works

Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease

Alabrahim, O. A. A., & Azzazy, H. M. E.-S. (2022) · Nanoscale Advances · doi:10.1039/d2na00524g · Cited by 54 · see citing works

Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders

Wu, Y., & Angelova, A. (2023) · Nanomaterials · doi:10.3390/nano13233004 · Cited by 53 · see citing works

Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells

Şahin, A., Yöyen-Ermiş, D., Caban-Toktas, S., Horzum, U., Aktaş, Y., Couvreur, P., Esendağlı, G., & Çapan, Y. (2017) · Journal of Microencapsulation · doi:10.1080/02652048.2017.1375039 · Cited by 52 · see citing works

Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration

Caban-Toktas, S., Şahin, A., Lüle, S., Esendağlı, G., Vural, İ., Oğuz, K. K., Söylemezoğlu, F., Mut, M., Dalkara, T., Khan, M. A., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119076 · Cited by 50 · see citing works

Current approaches to facilitate improved drug delivery to the central nervous system

Markowicz-Piasecka, M., Darłak, P., Markiewicz, A., Sikora, J., Adla, S. K., Bagina, S., & Huttunen, K. M. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.11.003 · Cited by 48 · see citing works

Targeted Brain Delivery Nanoparticles for Malignant Gliomas

Pinto, M. P., Arce, M., Yameen, B., & Vilos, C. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0307 · Cited by 47 · see citing works

Brain Targeting, Antioxidant Polymeric Nanoparticles for Stroke Drug Delivery and Therapy

Wu, H., Peng, B., Mohammed, F. S., Gao, X., Qin, Z., Sheth, K. N., Zhou, J., & Jiang, Z. (2022) · Small · doi:10.1002/smll.202107126 · Cited by 47 · see citing works

Mfsd2a-based pharmacological strategies for drug delivery across the blood–brain barrier

Wang, J.-Z., Xiao, N., Zhang, Y.-Z., Zhao, C., Guo, X., & Lu, L.-M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.024 · Cited by 45 · see citing works

Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies

Karthivashan, G., Ganesan, P., Park, S., Lee, H., & Choi, D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119704 · Cited by 45 · see citing works

The role of growth factors as a therapeutic approach to demyelinating disease

Huang, Y., & Dreyfus, C. F. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.02.023 · Cited by 43 · see citing works

Nanoparticle Therapy Is a Promising Approach in the Management and Prevention of Many Diseases: Does It Help in Curing Alzheimer Disease?

Kassem, L. M., Ibrahim, N., & Farhana, S. A. (2020) · Journal of Nanotechnology · doi:10.1155/2020/8147080 · Cited by 43 · see citing works

Therapeutic Nanoparticles for the Different Phases of Ischemic Stroke

Bernardo-Castro, S., Albino, I., Barrera-Sandoval, Á. M., Tomatis, F., Sousa, J. A., Martins, E., Simões, S. M. N., Lino, M. M., Ferreira, L., & Sargento‐Freitas, J. (2021) · Life · doi:10.3390/life11060482 · Cited by 45 · see citing works

Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke

Fukuta, T., Ishii, T., Asai, T., & Oku, N. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00683 · Cited by 42 · see citing works

The Application of Nanoparticles for Neuroprotection in Acute Ischemic Stroke

Chen, L., & Gao, X. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0023 · Cited by 36 · see citing works

Advanced Functional Materials and Cell‐Based Therapies for the Treatment of Ischemic Stroke and Postischemic Stroke Effects

Tapeinos, C., Larrañaga, A., Tomatis, F., Bizeau, J., Marino, A., Battaglini, M., Pandit, A. S., & Ciofani, G. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201906283 · Cited by 35 · see citing works

Autophagy-Associated lncRNAs: Promising Targets for Neurological Disease Diagnosis and Therapy

Xu, X., Cui, L., Zhong, W., & Cai, Y. (2020) · Neural Plasticity · doi:10.1155/2020/8881687 · Cited by 33 · see citing works

Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for Parkinson's disease

Saraiva, C., Ferreira, L., & Bernardino, L. I. (2016) · Neurogenesis · doi:10.1080/23262133.2016.1256855 · Cited by 32 · see citing works

Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides

Yemişçi, M., Caban-Toktas, S., Fernández-Megía, E., Çapan, Y., Couvreur, P., & Dalkara, T. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7571-6_36 · Cited by 30 · see citing works

Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides

Lin, J., Yu, Z., & Gao, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c06851 · Cited by 26 · see citing works

Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke

Grayston, A., Zhang, Y., García‐Gabilondo, M., Arrúe, M., Martín, A., Kopčanský, P., Timko, M., Kováč, J., Štrbák, O., Castellote, L., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211028816 · Cited by 25 · see citing works

Nanotechnology approaches to drug delivery for the treatment of ischemic stroke

Peng, B., Mohammed, F. S., Tang, X., Liu, J., Sheth, K. N., & Zhou, J. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.016 · Cited by 24 · see citing works

The role of lncRNAs in ischemic stroke

Chen, J., Liu, P., Dong, X., Jin, J., & Xu, Y. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105019 · Cited by 25 · see citing works

Polysaccharides meet dendrimers to fine-tune the stability and release properties of polyion complex micelles

Lopez-Blanco, R., Fernandez‐Villamarin, M., Jatunov, S., Novoa-Carballal, R., & Fernández-Megía, E. (2019) · Polymer Chemistry · doi:10.1039/c9py00727j · Cited by 23 · see citing works

A review of chitosan polysaccharides: Neuropharmacological implications and tissue regeneration

Hamdan, Y. A., El‐Mansoury, B., Elouali, S., Rachmoune, K., Belbachir, A., Oudadesse, H., & Rhazi, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135356 · Cited by 23 · see citing works

Drug delivery platforms for neonatal brain injury.

Narayanamurthy, R., Yang, J.-L. J., Yager, J., & Unsworth, L. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.056 · Cited by 19 · see citing works

BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR

Makani, V. S., Jang, Y.-G., Christopher, K., Judy, W., Eckstein, J. M., Hensley, K., Chiaia, N. L., Kim, D.-S., & Park, J. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149715 · Cited by 21 · see citing works

Targeting central nervous system pathologies with nanomedicines

Mizrahy, S., Gutkin, A., Decuzzi, P., & Peer, D. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1533556 · Cited by 22 · see citing works

A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis

Collongues, N., Becker, G., Jolivel, V., Ayme-Dietrich, E., de Séze, J., Binamé, F., Patte-Mensah, C., Monassier, L., & Mensah-Nyagan, A. (2022) · Neurological Therapeutics · doi:10.1007/s40120-022-00363-7 · Cited by 16 · see citing works

Nanotechnological Advancements in the Brain Tumor Therapy: a Novel Approach

Angolkar, M., Paramshetti, S., Halagali, P., Jain, V. K., Patil, A. B., & Somanna, P. (2022) · Therapeutic Delivery · doi:10.4155/tde-2022-0035 · Cited by 20 · see citing works

Chitosan‐Based Drug Delivery Systems

Peptu, C., Enache, A.-C., Rotaru, R., Fortună, M. E., Patraș, X., Teodorescu, M., Tamba, B.-I., & Harabagiu, V. (2019) · doi:10.1002/9781119450467.ch11 · Cited by 19 · see citing works

Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases

Nguyen, H., Aum, D., Mashkouri, S., Rao, G., Gonzales-Portillo, J. D. V., Reyes, S., & Borlongan, C. V. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1184086 · Cited by 18 · see citing works

Advances in nanotechnology-assisted photodynamic therapy for neurological disorders: a comprehensive review

Nasır, A., Rehman, M. U., Khan, T., Husn, M., Khan, M., Khan, A., Nuh, A. M., Jiang, W., Farooqi, H. M. U., & Bai, Q. (2024) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2024.2304814 · Cited by 18 · see citing works

Biomaterial-Based bFGF Delivery for Nerve Repair

Huang, Q., Liu, B., & Wu, W.-C. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/8003821 · Cited by 19 · see citing works

Drug delivery mediated by confined nanosystems: structure-activity relations and factors responsible for the efficacy of formulations

Zakharova, L. Y., Pashirova, T. N., Kashapov, R. R., Gabdrakhmanov, D. R., & Sinyashin, O. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00024-5 · Cited by 17 · see citing works

Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer’s Disease

Nguyen, T. T., Vo, T. K., & Vo, G. V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_13 · Cited by 17 · see citing works

The critical role of Sirt1 in ischemic stroke

Jia, Z., Xu, K., Li, R., Yang, S., Chen, L., Zhang, Q., Li, S., & Sun, X.-W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1425560 · Cited by 14 · see citing works

Influencing neuroplasticity in stroke treatment with advanced biomaterials-based approaches

Obermeyer, J. M., Ho, E., Gracias, A., & Shoichet, M. S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.012 · Cited by 13 · see citing works

The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases

Farhoudi, M., Sadigh‐Eteghad, S., Mahmoudi, J., Farjami, A., Mahmoudian, M., & Salatin, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220608093639 · Cited by 13 · see citing works

Toxicological Aspects of Iron Oxide Nanoparticles

Fernández‐Bertólez, N., Costa, C., Brandão, F., Teixeira, J. P., Pásaro, E., Valdiglesias, V., & Laffón, B. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-88071-2_13 · Cited by 12 · see citing works

Polymeric Nanoparticles in Hybrid Catalytic Processing and Drug Delivery System

Rajan, R., Pal, K., Jayadev, D., Jayan, J. S., Aathira, U., Saritha, A., de Souza, F. G., Joseph, K., & Kumar, S. S. (2022) · Topics in Catalysis · doi:10.1007/s11244-022-01697-0 · Cited by 11 · see citing works

The Progress in Molecular Transport and Therapeutic Development in Human Blood–Brain Barrier Models in Neurological Disorders

Korszun, J., Krysiak, Z. J., Saluk, J., Niemcewicz, M., & Zdanowski, R. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01473-6 · Cited by 11 · see citing works

The Neuropeptide PACAP, a Potent Disease Modifier Candidate for Brain Stroke Treatment

Brifault, C., Vaudry, D., & Wurtz, O. (2016) · Current topics in neurotoxicity · doi:10.1007/978-3-319-35135-3_34 · Cited by 10 · see citing works

Anatomy and Physiology of the Blood–Brain Barrier

Özdemir, Y., & Taş, Y. Ç. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803796-6.00001-0 · Cited by 10 · see citing works

Stealthiness and Hematocompatibility of Gold Nanoparticles with Pre-Formed Protein Corona

Yeo, E. L. L., Azman, N. ‘., & Kah, J. C. Y. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c00151 · Cited by 10 · see citing works

Modified CFBP-bFGF targeting to ischemic brain promoted the functional recovery of cerebral ischemia

Deng, J., Zhang, X., Yin, M., Cao, W., Zhang, B., Liu, Q., Hou, X., Wang, H., & Shi, C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.007 · Cited by 9 · see citing works

Fibroblast growth factor 9 (FGF9)‐mediated neurodegeneration: Implications for progressive multiple sclerosis?

Thümmler, K., Wrzos, C., Franz, J., McElroy, D., Cole, J. J., Hayden, L., Arseni, D., Schwarz, F., Junker, A., Edgar, J. M., et al. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12935 · Cited by 8 · see citing works

Challenges and barriers

Nance, E. A., & McKenna, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816662-8.00007-2 · Cited by 7 · see citing works

Pharmacological action, mechanism and structure-activity relationship of traditional Chinese medicine polysaccharide in the treatment of Alzheimer's disease: A review

Zhou, J., Guo, X., Yu, W., Bu, H., Du, Y., Li, S., Kuang, H., & Wu, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148017 · Cited by 6 · see citing works

Serum Level of Transferrin Unique Peptide Is Decreased in Patients With Acute Ischemic Stroke

Hu, X., Li, Y., Cheng, P., Wu, A., & Li, G. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.619310 · Cited by 5 · see citing works

Expression, Functional Polymorphism, and Diagnostic Values of MIAT rs2331291 and H19 rs217727 Long Non-Coding RNAs in Cerebral Ischemic Stroke Egyptian Patients

Motawi, T. K., Sadik, N. A. H., Shaker, O. G., Ghaleb, M. H., & Elbaz, E. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020842 · Cited by 5 · see citing works

Applications of Nanomaterials in Neurological Diseases, Neuronal Differentiation, Neuronal Protection, and Neurotoxicity

Alhibshi, A., Alamoudi, W., & Farooq, R. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-4802-4_6 · Cited by 5 · see citing works

A review of glucoregulatory hormones potentially applicable to the treatment of Alzheimer’s disease: mechanism and brain delivery

Amatya, R., Min, K. A., & Shin, M. C. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00566-y · Cited by 4 · see citing works

Chitosan-based nanoparticles for targeted delivery of 17β-estradiol to enhance SIRT1-mediated autophagy and mitigate rotenone-induced Parkinson's disease

Biswal, L., Ayoub, M., Ghosh, D., Sahu, V. K., Choudhury, S. R., & Karmakar, S. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02351c · Cited by 3 · see citing works

Nano revolutions in ischemic stroke: A critical analysis of current options and the potential of nanomedicines in diagnosis and therapeutics

Belgamwar, A. V., Sharma, R., Mali, Y., Agrawal, Y. O., & Nakhate, K. T. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.10.022 · Cited by 4 · see citing works

A novel hydroxytyrosol derivative HT-3 enhances antioxidant and neuroprotective activity through efficient molecular conjugation

Zhang, L., Wei, H., Han, T., Shi, S., Zhang, X., Shi, X., Zhang, H., & Zhang, B. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108484 · Cited by 3 · see citing works

Introduction

Jain, K. K. (2019) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4939-9465-6_1 · Cited by 3 · see citing works

Modafinil‐coated nanoparticle increases expressions of brain‐derived neurotrophic factor, glial cell line‐derived neurotrophic factor and neuronal nuclear protein, and protects against middle cerebral artery occlusion‐induced neuron apoptosis in the rat hippocampus

Torfeh, A., Abdolmaleki, Z., Nazarian, S., & Beheshtiha, S. H. S. (2020) · The Anatomical Record · doi:10.1002/ar.24581 · Cited by 3 · see citing works

Polymeric Nanomedicine

Zhao, Y., Zheng, C., & Liu, Y. (2019) · Springer eBooks · doi:10.1007/978-981-13-8731-9_9 · Cited by 3 · see citing works

New Insights into Nanoparticulate Carriers for Direct Nose‐to‐Brain Drug Delivery

Pardeshi, C. V., Handa, M., & Shukla, R. (2021) · doi:10.1002/9783527832095.ch9 · Cited by 3 · see citing works

Advanced Polymeric Nanoparticles for the Treatment of Neurodegenerative Diseases

Ferrão, R., & Rai, A. (2024) · Wiley eBooks · doi:10.1002/9783527837021.ch27 · Cited by 3 · see citing works

Nanomedicine-based therapeutic strategies for cerebral ischemia–reperfusion injury: from blood–brain barrier penetration to precision targeting

Guo, X., Liu, G., Liu, Y., Jin, M., Zihao, Y. O. N. G., Li, F., Tang, S., Xie, L., Huang, C., Mu, Q., et al. (2026) · European journal of medical research · doi:10.1186/s40001-026-04073-w · Cited by 2 · see citing works

Cardiopulmonary bypass in a rat model may shorten the lifespan of stored red blood cells by activating caspase-3

Han, L., Li, L., Linghu, H., Zheng, L., & Gou, D.-M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290295 · Cited by 2 · see citing works

Lessons from Experimental-Induced Atherosclerosis: Valuable for the Precision Medicine of Tomorrow

Călin, M., Butoi, E. D., Manea, S., Simionescu, M., & Manea, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-34193-4_17 · Cited by 2 · see citing works

Novel drug delivery systems in cerebral vascular disorders, transient ischaemic attack, and stroke interventions

Ranjan, R., Kumar, D., Singh, M. R., & Singh, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00009-3 · Cited by 1 · see citing works

NEUROPROTECTIVE ROLE OF BASIC FIBROBLAST GROWTH FACTOR IN ISCHEMIC BRAIN LESION: A REVIEW

Ostrova, I. V., & Avrushchenko, M. S. (2016) · General Reanimatology · doi:10.15360/1813-9779-2015-6-48-60 · Cited by 1 · see citing works

Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides

Yemişçi, M., Caban-Toktas, S., Fernández-Megía, E., Çapan, Y., Couvreur, P., & Dalkara, T. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7571-6_36 · Cited by 30 · see citing works

Transport of a Caspase Inhibitor Across the Blood–Brain Barrier by Chitosan Nanoparticles

Yemişçi, M., Özdemir, Y., Caban-Toktas, S., Bodur, E., Çapan, Y., & Dalkara, T. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00013-6 · Cited by 36 · see citing works

Targeted delivery of BDNF-loaded poly (lactide-co-glycolide) nanoparticle to the brain: penetration through blood brain barrier and neuroprotective effect in stroke / Siti Norsyafika Kamarudin

Kamarudin, S. N. (2019) · UiTM Institutional Repositories (Universiti Teknologi MARA)

A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection

Karataş, H., Aktaş, Y., Özdemir, Y., Bodur, E., Yemişçi, M., Caban-Toktas, S., Vural, A., Pınarbaşlı, O., Çapan, Y., Fernández-Megía, E., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4246-09.2009 · Cited by 187 · see citing works

Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke

Li, R., Huang, Y., Chen, L., Zhou, H.-H., Zhang, M., Chang, L., Shen, H. Y., Zhou, M., Su, P., & Zhu, D. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.10.013 · Cited by 67 · see citing works